Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells. (Q54268375)

27 May 2018

title

Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells. (English)

1 reference

27 May 2018

1 reference

Guojun Zhang

1

1 reference

27 May 2018

Zhe Zhang

series ordinal

2

1 reference

27 May 2018

Zhuogang Liu

series ordinal

3

1 reference

27 May 2018

publication date

14 March 2013

1 reference

27 May 2018

published in

Tumor Biology

1 reference

27 May 2018

volume

34

1 reference

27 May 2018

issue

3

1 reference

27 May 2018

page(s)

1887-1894

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-013-0732-0

exact match

0 references

cites work

Kinase inhibitors: a new class of antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Polo-like kinase 1, on the rise from cell cycle regulation to prostate cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Mammalian neurogenesis requires Treacle-Plk1 for precise control of spindle orientation, mitotic progression, and maintenance of neural progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Polo-like kinase 1 regulates activation of AMP-activated protein kinase (AMPK) at the mitotic apparatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Inhibition of Plk1 and Pin1 by 5'-nitro-indirubinoxime suppresses human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Polo-like kinase 1 inhibitors and their potential role in anticancer therapy, with a focus on NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Study of the docking-dependent PLK1 phosphorylation of the CDC25B phosphatase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Polo-like kinase 1 may regulate G2/M transition of mouse fertilized eggs by means of inhibiting the phosphorylation of Tyr 15 of Cdc2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Progress in the discovery of polo-like kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

Polo-like kinase-1 is a target of the DNA damage checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0732-0

In vitro PLK1 inhibition by BI 2536 decreases proliferation and induces cell-cycle arrest in melanoma cells

21 January 2018

1 reference

12 December 2020

Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5.

1 reference

12 December 2020

Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma.

1 reference

12 December 2020

Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer

1 reference

12 December 2020

10.1007/S13277-013-0732-0

Identifiers

DOI

1 reference

27 May 2018

release_twsrnpz3nratnkjztk2pjfgsei

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/twsrnpz3nratnkjztk2pjfgsei

24 November 2022

mapped directly with Wikidata item

1 reference

27 May 2018